Abstract:Higher sensitivity of pericardial fluid cytology than biopsy in malignant effusions. Lung adenocarcinoma is the most common type in malignant pericardial effusion. A multi‐institutional study reviewed 309 cases of pericardial fluid cytology and pericardial biopsy, highlighting greater sensitivity of cytology (84.8%) with the most common primaries being lung, breast, gastrointestinal, and haematologic origin. The study also commented on the impact of ancillary testing, volume of pericardial fluid submitted for analysis, and utilization of molecular diagnostics like cfDNA methylation analysis for further enhancement of diagnostic accuracy and improved patient outcomes. Objective Malignant pericardial effusions are associated with a poor prognosis. Pericardial fluid cytology and pericardial biopsy are the primary methods for diagnosis. This study aimed to conduct a multi‐institutional analysis to compare the diagnostic sensitivity of cytology and biopsy, and to investigate potential explanations for false‐negative results in cytology. Methods A retrospective review of pericardial fluid cytology cases with concurrent biopsy was conducted across four different institutions. Results were compared using standard statistical methods with attention to sensitivity and histologic distribution. False‐negative cytology cases were investigated for further exploration. Results A total of 309 cases were collected, of which 99 (32.0%) were confirmed malignant through repeat sampling or clinical history. Pericardial fluid cytology and biopsy identified 84 and 64 malignant cases, respectively. Our findings confirmed significantly higher sensitivity of cytology compared to biopsy (84.8% vs 65.7%). The most common sites of origin were lung, breast, and gastrointestinal, with adenocarcinoma being the most prevalent histologic subtype. Histologic review of 12 false‐negative cytology cases revealed three key explanations; lymphoma was the most common missed diagnosis (33.3%); fibrinous pericarditis obscures neoplastic cells on the pericardial surface; and pericardial involvement can be seen without extension into the pericardial space. Conclusion This study demonstrated diagnostic superiority of pericardial fluid cytology over biopsy in the evaluation of malignant pericardial effusions. We identified several limitations in fluid cytology causing false negatives. In the context of an underlying malignancy with pericardial effusion, pathologists should consider immunohistochemistry studies to aid on the diagnosis.

Analyses of Malignant Cell of Pleural Effusion,Ascites and Pericardial Effusion

Cytomorphological Analyses of 2240 Samples of Pleural Effusion,ascites and Pericardial Effusion

The study of pleural lavage cytology for lung cancer

Clinical and cytopathologic characteristics of lymphoid neoplasms involved with serous effusions: a single center experience

Clinical and laboratory characteristics of lymphoid neoplasms in serous effusions: a single centre experience in China

Values of immunocytochemical and quantitative morphometric analyses in cytological differential diagnosis of pleural and peritoneal effusion

Immunohistochemical detection and molecular pathological examination of 142 cases of malignant pleural effusion

Clinical Analysis of 172 Cases of Malignant Pleural Effusion with Lung Cancer

Diagnostic Value of Thin-Cytological Test and Routine Cytological Detection for Patients

Significance of Combining Detection of E-cadherin, Carcinoembryonic Antigen,and Calretinin in Cytological Differential Diagnosis of Serous Effusion

Research on the Correlation of Serous Membrane Cavity Exfoliative Cytology Examination and Tumor Marker Levels

Cytological Analysis of Malignant Serous Cavity Effusion with Eosinophilia

Identification the proliferous mesothelial cells and adenocarcinoma by dropsy of serous cavity cell immunochemistry staining

Detection of Carcinoma in Serous Effusions: a Review.

Determination of Ki-67 Expression and Its Significance in Cell Smears of Pleural Effusion and Ascites using Thin-layer Cytology Test

Clinical and cytological characteristics of serous effusions in 69 cases of lymphoma patients

Retrospective Investigation of Flow Cytometric DNA Analysis in of Malignant Cells in Peritoneal and Pleural Fluids

Diagnostic Value of Pericardial Fluid Examination for Benign and Malignant Pericardial Effusion

Higher sensitivity of pericardial fluid cytology than biopsy in malignant effusions with potential explanation of false‐negative cytology: A multi‐institutional analysis

Application value of combined detection of exfoliative cytology,DNA heteroploid analysis and serum tumor marker in malignant pleural/ascitic fluid

Diagnosis and categorization of malignant effusions: A 6‐year review from a single academic institution